Skip to main content
Zoetis Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
Made on Aug 13, 2026
Price at call $73.54
6-month call Bull +12.6%
Target by Feb 2027 $82.80
Great value below $60.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change +12.6% to $82.80
Predicted High $82.80 at 6 months
Predicted Low $73.90 in 2 weeks

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 13, 2026 1:04 am
Bull ZTS trends higher to $82.80 (+12.6% from $73.54) by Feb 2027. flat-then-break
ThesisZTS is a high-quality animal-health compounder trading at a deep discount after a 42% drawdown, but sentiment is broken and there is no near-term catalyst. Expect base-building near current levels for weeks, then a gradual mean-reversion toward the composite fair value as the risk-on tape and quality bid re-emerge.
Invalidated ifA break below $65 on new guide-down news, or failure to reclaim $78 by month 3, would invalidate the recovery thesis.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $73.54 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 13, 2026 $73.54 at call The anchor — every point below is measured from this price and date.
2 weeks Aug 27, 2026 $68.82–$78.26 typical range · internal point $73.90 ±6.4% 6/10 Base-building near lows, no catalyst, low beta
1 month Sep 13, 2026 $66.69–$80.39 typical range · internal point $74.80 ±9.3% 5/10 Sentiment stabilizing, risk-on tape supportive
2 months Oct 13, 2026 $76.50 +4.0% 5/10 Signal-adjusted fair value pulls price higher
3 months Nov 13, 2026 $78.20 +6.3% 4/10 Q3 print approaches, quality bid returns
4 months Dec 13, 2026 $80.00 +8.8% 4/10 Earnings beat likely, guide reset digested
5 months Jan 13, 2027 $81.50 +10.8% 4/10 Value convergence toward DCF anchor
6 months Feb 13, 2027 $82.80 +12.6% 3/10 Gradual re-rating toward composite fair value

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $80.72 (+9.8%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

0 blocking · 0 degraded · 1 note — follow the chain top-down (cause → effect).
  • Note
    Valuation anchor absent: anchored_pe.
    anchor:anchored_pe

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$73.54
Composite fair value$85.65
Signal-adjusted fair value$76.88
DCF fair value$82.02
Anchored-PE fair value
Buy-below (value lens)$60.00
Value net score+4
Value confidence5 / 10
Quality net score+69
Memo confidence6 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 35.3%  3m 32.3%  6m 46.4%  
Daily σ (realism noise)2.0%
Beta vs S&P 500 1m -0.56  3m -0.30  5m 0.42  
Trailing 6-month return-42.6%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Jul 30, 2026 13d behind ZTS-20260730-170254-8439
ext-forensic-memo Aug 13, 2026 freshest ext-ZTS-20260813-002809-477c
ext-lens-quality Aug 13, 2026 freshest ext-ZTS-20260813-002809-477c
ext-lens-sentiment Aug 13, 2026 freshest ext-ZTS-20260813-002809-477c
ext-lens-value Aug 13, 2026 freshest ext-ZTS-20260813-002809-477c
scenario-valuation Aug 13, 2026 freshest ZTS-20260813-001151-fb8a
valuation-synthesis Aug 13, 2026 freshest ZTS-20260813-001151-fb8a

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 13, 2026 v0.6.0 Bull $73.54 $82.80 +12.6% Feb 2027 viewing
Jul 22, 2026 v0.6.0 Bull $75.33 $86.50 +14.8% Jan 2027 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.